Oxaliplatin Injection, Solution
Product Images NDC 71288-101

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 71288-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Oxa0h 0002 01)

Chemical structure of Oxaliplatin showing the platinum (Pt) central atom bonded to a cyclohexane-1,2-diamine ligand and two oxalate groups.*

FDA Label Image

Figure 1 (Oxa0h 0002 02)

A Kaplan-Meier survival plot showing disease-free survival (DFS) probability over 72 months for two treatment arms: FOLFOX4 and LV5FU2. The graph includes event counts, hazard ratio with confidence interval, and p-value for stratified logrank test, depicting patient survival comparison between arms.*

FDA Label Image

Figure 2 (Oxa0h 0002 03)

A Kaplan-Meier plot showing Disease-Free Survival (DFS) probability over time in months for two treatment arms, FOLFOX4 and LV5FU2, in Stage III patients. The plot includes a hazard ratio of 0.78 with a 95% confidence interval and a Logrank test p-value of 0.005, illustrating comparative survival outcomes between treatments.*

FDA Label Image

Figure 3 (Oxa0h 0002 04)

A line graph showing median survival in months of patients under different treatments: Oxaliplatin Injection plus 5-FU/LV, Oxaliplatin Injection plus Irinotecan, and Irinotecan plus 5-FU/LV. The graph plots percent of patients surviving over a 24-month period, with Oxaliplatin plus 5-FU/LV demonstrating the highest median survival among the groups.*

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 50 mg Vial Label)

Label for Oxaliplatin Injection, USP 50 mg per 10 mL (5 mg per mL) intravenous solution in a 10 mL single-dose vial. The label indicates it is a cytotoxic agent and not to be mixed with sodium chloride or chloride-containing solutions. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, made in India.*

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 50 mg Carton)

Packaging label for Oxaliplatin Injection USP 50 mg per 10 mL (5 mg per mL) solution, intravenous use. The label includes warnings that it is a cytotoxic agent and should not be mixed with sodium chloride solutions. It indicates a single-dose 10 mL vial, sterile aqueous solution, preservative-free. Labeler is Meitheal Pharmaceuticals Inc., Chicago, IL, with barcode and NDC 71288-101-10.*

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 100 mg Vial Label)

Oxaliplatin 100 mg per 20 mL (5 mg per mL) Injection, USP label for intravenous use. The label indicates a 20 mL single-dose vial and includes warnings such as the product being preservative-free, cytotoxic, and instructions not to mix with sodium chloride or chloride-containing solutions. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, made in India, with storage instructions to keep 20 to 25°C and protect from light.*

FDA Label Image

Principal Display Panel (Oxaliplatin Injection, USP 100 mg Carton)

Carton label for Oxaliplatin Injection, USP 100 mg per 20 mL (5 mg per mL) single-dose vial, by Meitheal Pharmaceuticals Inc. The label includes dosing information for intravenous use only, warnings that it is a cytotoxic agent and should not be mixed or added to sodium chloride/chloride-containing solutions, storage instructions, and a barcode. The package contains one 20 mL vial of sterile aqueous solution, preservative-free.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.